-
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Rating of "Moderate Buy" from Analysts
ソース: Buzz FX / 22 2 2025 02:21:13 America/New_York
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Rating of "Moderate Buy" from Analysts Written by MarketBeat February 22, 2025 Share Link copied to clipboard. Crinetics Pharmaceuticals, Inc.
Read more...